Channel Medsystems closed a series C-1 financing of $14.1 million led by insider investors. The company has developed a the Cerene physician-office cryotherapy device for heavy menstrual bleeding. Funds will be applied to efforts to seek FDA approval of the device, and for commercialization at a later date.